CJC 1295 Ipamorelin Side Effects: Research CJC 1295 Ipamorelin Side Effects: Research Item added to your cart When a customer selects CJC-1295 or Ipamorelin from the product list, the e-commerce platform automatically records this choice in the shopping cart. The system updates inventory levels, applies any applicable discounts or promotions, and recalculates the total cost. At this point, the user is prompted to continue browsing or proceed to checkout. If a coupon code is entered, the cart will recalculate the final price before the user confirms the purchase. The backend also logs this action for analytics purposes, helping the retailer track popular products and adjust stock accordingly. CJC 1295 Ipamorelin Side Effects: Research Both CJC-1295 and Ipamorelin are growth hormone secretagogues that stimulate endogenous release of human growth hormone (HGH). Extensive laboratory studies and a growing body of clinical case reports have identified several potential side effects associated with their use. Short-term adverse reactions During initial dosing, patients frequently report mild injection site pain, localized swelling, or redness. These symptoms are generally transient and resolve within 24–48 hours. Some users experience transient headaches, dizziness, or a sense of fullness in the face, likely due to increased vascular permeability mediated by elevated HGH levels. Metabolic changes Chronic exposure to elevated HGH can alter glucose metabolism. In controlled studies involving healthy volunteers, insulin sensitivity has shown slight improvement, but in some cases, blood glucose excursions have been noted, particularly when combined with other anabolic agents. This underscores the importance of periodic fasting glucose or HbA1c monitoring for long-term users. Edema and fluid retention Both peptides can induce peripheral edema.